Clinical serum metabolomics study on fluoxetine hydrochloride for depression
- 1 February 2021
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 746, 135585
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81503390, 82074220)
This publication has 23 references indexed in Scilit:
- Metabolomic identification of biochemical changes induced by fluoxetine and imipramine in a chronic mild stress mouse model of depressionScientific Reports, 2015
- Fluoxetine: a case history of its discovery and preclinical developmentExpert Opinion on Drug Discovery, 2014
- Neurobiology of resilienceNature Neuroscience, 2012
- Key Role of Polyphosphoinositides in Dynamics of Fusogenic Nuclear Membrane VesiclesPLOS ONE, 2011
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- The effect of selective serotonin re‐uptake inhibitors on the risk of myocardial infarction in a cohort of patients with depressionBritish Journal of Clinical Pharmacology, 2011
- Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS)Frontiers in Neuroendocrinology, 2009
- Systems biology, metabolic modelling and metabolomics in drug discovery and developmentDrug Discovery Today, 2006
- Dopamine, depression and antidepressantsFundamental & Clinical Pharmacology, 2004
- Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transportBiochemical Journal, 1979